Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Total Current Liabilities (2016 - 2025)

Standard Biotools (LAB) has disclosed Total Current Liabilities for 16 consecutive years, with $108.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Current Liabilities fell 10.49% to $108.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $108.0 million, a 10.49% decrease, with the full-year FY2024 number at $65.9 million, down 39.73% from a year prior.
  • Total Current Liabilities was $108.0 million for Q3 2025 at Standard Biotools, up from $98.0 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $123.8 million in Q2 2024 to a low of $42.8 million in Q2 2022.
  • A 5-year average of $75.2 million and a median of $56.2 million in 2025 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: soared 177.6% in 2024, then tumbled 53.74% in 2025.
  • Standard Biotools' Total Current Liabilities stood at $49.6 million in 2021, then fell by 12.36% to $43.4 million in 2022, then surged by 151.66% to $109.3 million in 2023, then plummeted by 39.73% to $65.9 million in 2024, then skyrocketed by 63.84% to $108.0 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Total Current Liabilities are $108.0 million (Q3 2025), $98.0 million (Q2 2025), and $56.2 million (Q1 2025).